Hematology and Oncology Discovery is a peer reviewed, open access journal on hematology and oncology research, spanning from basic laboratory, translational to clinical investigations. The journal aims to provide a platform for hematologists and oncologists to communicate practical experiences to facilitate real-case diagnosis and treatments as well as adoption of latest physiological and biological advances and new technologies derived, and to inspire researchers to tackle challenges from clinical settings. Besides original research, reviews, case studies and clinical trials, the journal is particularly interested in summary of individual opinion on specific disorder facilitating clinical practice.
The journal encourages clinicians and physicians to take a holistic and multidisciplinary angle when discussing their cases and in particular, when pursuing solutions for hematologic malignancies, tumors and complications:
- Gene therapy and application in patient care
- Immunotherapy and Immunobiology
- Transplantation
- Observations on pathological discoveries, e.g., molecular pathways, genomics etc.
- Rare diseases in hematology and oncology
Submissions to Hematology and Oncology Discovery are made using ScholarOne, the online submission and peer review system. Registration and access are available at https://mc04.manuscriptcentral.com/hemoncdisc